Is Biofrontera Inc. (BFRI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 49.2% / 30% | 59.1% / 30% | 53.1% / 30% | 0.19% / 5% | ✗ NOT HALAL |
| DJIM | 49.2% / 33% | 59.1% / 33% | 53.1% / 33% | 0.19% / 5% | ✗ NOT HALAL |
| MSCI | 22.3% / 33% | 26.7% / 33% | 24.0% / 33% | 0.19% / 5% | ✓ HALAL |
| S&P | 49.2% / 33% | 59.1% / 33% | 53.1% / 33% | 0.19% / 5% | ✗ NOT HALAL |
| FTSE | 22.3% / 33% | 26.7% / 33% | 24.0% / 50% | 0.19% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 73.7% | |
| Operating Margin | 26.7% | |
| Net Margin | -25.3% | |
| Return on Equity (ROE) | -141.3% | |
| Return on Assets (ROA) | -28.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$10M |
| Free Cash Flow | -$10M |
| Total Debt | $5M |
| Debt-to-Equity | 58.8 |
| Current Ratio | 1.5 |
| Total Assets | $22M |
Price & Trading
| Last Close | $0.81 |
| 50-Day MA | $0.88 |
| 200-Day MA | $0.88 |
| Avg Volume | 489K |
| Beta | 0.6 |
|
52-Week Range
$0.54
| |
About Biofrontera Inc. (BFRI)
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Biofrontera Inc. (BFRI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Biofrontera Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Biofrontera Inc.'s debt ratio?
Biofrontera Inc.'s debt ratio is 49.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 22.3%.
What are Biofrontera Inc.'s key financial metrics?
Biofrontera Inc. has a market capitalization of $10M, and revenue of $37M. The company maintains a gross margin of 73.7% and a net margin of -25.3%. Return on equity stands at -141.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.